Literature DB >> 14635041

Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza viruses.

Falk Nimmerjahn1, Dieter Kobelt, Alexander Steinkasserer, Annette Menke, Gerd Hobom, Uta Behrends, Georg W Bornkamm, Josef Mautner.   

Abstract

Adoptive transfer of in vitro generated antigen-specific T cells has been successfully used to treat viral infections in immunodeficient patients. Therefore, methods for the rapid in vitro expansion of antigen-specific T cells are needed. Influenza virus efficiently infects dendritic cells, and peptides derived from viral proteins are processed and presented to CD8(+) cytotoxic T cells. However, both, CD4(+) and CD8(+) T cells are necessary for the efficient control of viral infections, and it is becoming increasingly clear that a T helper cell response is very important for the maintenance and strength of the immune response. Here we show that recombinant influenza virus efficiently infects a wide range of professional antigen-presenting cells and does not interfere with antigen presentation pathways. Using T cell clones for three different MHC class II-restricted antigens we demonstrate that peptides derived from these antigens are efficiently presented on MHC class II molecules. Importantly, it was possible to generate and expand antigen-specific CD4(+) T cells following in vitro infection of professional antigen-presenting cells with recombinant influenza virus. These findings support the notion that recombinant influenza virus is a valuable tool for the expansion of antigen-specific CD4(+) T cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635041     DOI: 10.1002/eji.200324342

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach.

Authors:  Slavoljub Milosevic; Uta Behrends; Dinesh Adhikary; Josef Mautner
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

2.  Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.

Authors:  Inês Antunes; George Kassiotis
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

3.  Stringent doxycycline-dependent control of gene activities using an episomal one-vector system.

Authors:  Georg W Bornkamm; Christian Berens; Conny Kuklik-Roos; Jean-Marie Bechet; Gerhard Laux; Jürgen Bachl; Martin Korndoerfer; Martin Schlee; Michael Hölzel; Anastassia Malamoussi; Rob D Chapman; Falk Nimmerjahn; Josef Mautner; Wolfgang Hillen; Hermann Bujard; Jean Feuillard
Journal:  Nucleic Acids Res       Date:  2005-09-07       Impact factor: 16.971

4.  Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.

Authors:  Dinesh Adhikary; Uta Behrends; Andreas Moosmann; Klaus Witter; Georg W Bornkamm; Josef Mautner
Journal:  J Exp Med       Date:  2006-03-20       Impact factor: 14.307

Review 5.  Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.

Authors:  Dinesh Adhikary; Uta Behrends; Heike Boerschmann; Andrea Pfünder; Stefan Burdach; Andreas Moosmann; Klaus Witter; Georg W Bornkamm; Josef Mautner
Journal:  PLoS One       Date:  2007-07-04       Impact factor: 3.240

6.  Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.

Authors:  Takanobu Tagawa; Manuel Albanese; Mickaël Bouvet; Andreas Moosmann; Josef Mautner; Vigo Heissmeyer; Christina Zielinski; Dominik Lutter; Jonathan Hoser; Maximilian Hastreiter; Mitch Hayes; Bill Sugden; Wolfgang Hammerschmidt
Journal:  J Exp Med       Date:  2016-09-12       Impact factor: 14.307

7.  Pandemic Influenza A (H1N1) Virus Infection Increases Apoptosis and HIV-1 Replication in HIV-1 Infected Jurkat Cells.

Authors:  Xue Wang; Jiying Tan; Santanu Biswas; Jiangqin Zhao; Krishnakumar Devadas; Zhiping Ye; Indira Hewlett
Journal:  Viruses       Date:  2016-02-02       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.